136 related articles for article (PubMed ID: 10209520)
1. Mice with early onset of death (EOD) due to lupus glomerulonephritis.
Honda S; Nemoto K; Mae T; Kinjoh K; Kyogoku M; Kawamura H; Miyazawa S; Weerashinghe A; Watanabe H; Narita J; Koya T; Arakawa M; Abo T
Clin Exp Immunol; 1999 Apr; 116(1):153-63. PubMed ID: 10209520
[TBL] [Abstract][Full Text] [Related]
2. Marked acceleration of the autoimmune disease in MRL-lpr/lpr mice by the influence of the Yaa gene from BXSB mice.
Miyawaki S; Nakamura Y; Takeshita T; Yoshida H; Shibata Y; Mitsuoka S
Lab Anim Sci; 1988 Jun; 38(3):266-72. PubMed ID: 2970562
[TBL] [Abstract][Full Text] [Related]
3. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
[TBL] [Abstract][Full Text] [Related]
4. Morphological analysis of autoimmune disease in MRL-lpr,Yaa male mice with rapidly progressive systemic lupus erythematosus.
Suzuka H; Yoshifusa H; Nakamura Y; Miyawaki S; Shibata Y
Autoimmunity; 1993; 14(4):275-82. PubMed ID: 8347770
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.
Merino R; Shibata T; De Kossodo S; Izui S
Eur J Immunol; 1989 Nov; 19(11):2131-7. PubMed ID: 2599002
[TBL] [Abstract][Full Text] [Related]
6. A pivotal role of cell-bound but not soluble CD4 molecules in full development of lupus-like manifestations in MRL-Fas(lprcg)/Fas(lprcg) mice.
Zhang Y; Yasuda T; Wang CR; Yoshimoto T; Nagase H; Takamoto M; Tsubura A; Kimura M; Matsuzawa A
Clin Exp Immunol; 2000 Oct; 122(1):124-32. PubMed ID: 11012628
[TBL] [Abstract][Full Text] [Related]
7. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
Kikawada E; Lenda DM; Kelley VR
J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
Sadanaga A; Nakashima H; Masutani K; Miyake K; Shimizu S; Igawa T; Sugiyama N; Niiro H; Hirakata H; Harada M
Arthritis Rheum; 2005 Dec; 52(12):3987-96. PubMed ID: 16320345
[TBL] [Abstract][Full Text] [Related]
9. Studies on the mechanisms of the development of lupus nephritis in BXSB mice. II. Comparative studies between male BXSB and MRL/lpr mice at the onset period.
Makino M; Fujiwara M; Watanabe H
J Clin Lab Immunol; 1988 Feb; 25(2):83-8. PubMed ID: 3259631
[TBL] [Abstract][Full Text] [Related]
10. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
Yao L; Chen HP; Ma Q
Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
[TBL] [Abstract][Full Text] [Related]
11. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
Chalmers SA; Glynn E; Garcia SJ; Panzenbeck M; Pelletier J; Dimock J; Seccareccia E; Bosanac T; Khalil S; Harcken C; Webb D; Nabozny G; Fine JS; Souza D; Klein E; Herlitz L; Ramanujam M; Putterman C
Clin Immunol; 2018 Dec; 197():205-218. PubMed ID: 30339790
[TBL] [Abstract][Full Text] [Related]
12. The role of alpha beta+ T cells and homeostatic T cell proliferation in Y-chromosome-associated murine lupus.
Lawson BR; Koundouris SI; Barnhouse M; Dummer W; Baccala R; Kono DH; Theofilopoulos AN
J Immunol; 2001 Aug; 167(4):2354-60. PubMed ID: 11490025
[TBL] [Abstract][Full Text] [Related]
13. Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice.
Tada Y; Nagasawa K; Ho A; Morito F; Koarada S; Ushiyama O; Suzuki N; Ohta A; Mak TW
J Immunol; 1999 Sep; 163(6):3153-9. PubMed ID: 10477582
[TBL] [Abstract][Full Text] [Related]
14. Effect of cyclophosphamide on lymphokine production in MRL/lpr.Yaa mice.
Kamada H; Takaoka Y; Kitagaki K; Nagai H
Inflamm Res; 1995 Nov; 44(11):491-8. PubMed ID: 8597884
[TBL] [Abstract][Full Text] [Related]
15. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
[TBL] [Abstract][Full Text] [Related]
16. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice.
Elliott MK; Jarmi T; Ruiz P; Xu Y; Holers VM; Gilkeson GS
Kidney Int; 2004 Jan; 65(1):129-38. PubMed ID: 14675043
[TBL] [Abstract][Full Text] [Related]
17. An allogeneic microenvironment influences the phenotype of intermediate T-cell receptor cells expanding in MRL-lpr/lpr mice.
Tsukahara A; Iiai T; Moroda T; Tada T; Suzuki S; Takeda K; Hatakeyama K; Abo T
Immunology; 1998 Jun; 94(2):149-59. PubMed ID: 9741335
[TBL] [Abstract][Full Text] [Related]
18. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
Matsumoto K; Watanabe N; Akikusa B; Kurasawa K; Matsumura R; Saito Y; Iwamoto I; Saito T
Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
[TBL] [Abstract][Full Text] [Related]
19. IgG3 deficiency extends lifespan and attenuates progression of glomerulonephritis in MRL/lpr mice.
Greenspan NS; Lu MA; Shipley JW; Ding X; Li Q; Sultana D; Kollaros M; Schreiber JR; Fu P; Putterman C; Emancipator SN
Biol Direct; 2012 Jan; 7():3. PubMed ID: 22248284
[TBL] [Abstract][Full Text] [Related]
20. The Friend leukaemia virus integration 1 (Fli-1) transcription factor affects lupus nephritis development by regulating inflammatory cell infiltration into the kidney.
Sato S; Zhang XK
Clin Exp Immunol; 2014 Jul; 177(1):102-9. PubMed ID: 24580413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
